# Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

> **NCT00867971** · — · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Growth Hormone Treatment
- Glaucoma

## Interventions

- **OTHER:** Measuring intraoccular pressure

## Key facts

- **NCT ID:** NCT00867971
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867971, "Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00867971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
